Clin2
NCT06968312Possibly a fitRecruiting

Hexadecanal added to therapy for PTSD

Post Traumatic Stress Disorder (PTSD)

Part of Mental health clinical trials.

This trial tests if a natural substance called hexadecanal, when added to standard talk therapy (Cognitive Processing Therapy), can help treat PTSD. It's for adults who have been diagnosed with PTSD and are able to receive therapy at a specific clinic.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with PTSD (post-traumatic stress disorder) based on current medical guidelines.
  • You are 18 years old or older.
  • You are eligible for Cognitive Processing Therapy at the National Center for Traumatic Stress and Resilience.
  • You do not have bipolar disorder, psychosis, or a neurological disorder.
  • You do not have a drug addiction.
  • You are not currently in another form of talk therapy.
  • You are not born with or have lost your sense of smell.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in U.S. service members

This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.

NCT07185126Recruiting
New PTSD therapy for children ages 6-14

This study tests a new therapy for children with PTSD. It aims to help children aged 6-14 reduce trauma symptoms by teaching them skills to manage distressing memories and feelings.

Kyiv
NCT07224698Not yet recruiting· Phase 2
Inhaled cannabis for treating PTSD in veterans

This study tests whether inhaling cannabis can help reduce PTSD symptoms in veterans. You will receive cannabis provided by the study team and have regular check-ins to see how it affects your symptoms.

NCT05732155Recruiting· Phase 2
MDMA-assisted therapy for war-related PTSD

This study tests whether combining MDMA with talk therapy can help people with post-traumatic stress disorder (PTSD) from war experiences. It involves both individual and group therapy sessions, and the medication is given during some sessions.

Afula
NCT06826937Recruiting
Short-term recall therapy for severe PTSD

This study tests a new therapy that uses short-term recall and reprocessing to help people with severe PTSD. It may help you if you have strong PTSD symptoms and are not currently in crisis or have certain other mental health conditions.

Beersheba
NCT05269459Recruiting· Phase 2
Cannabidiol (CBD) for PTSD symptoms in adults

This study tests whether CBD, a non-psychoactive compound from cannabis, can help reduce symptoms of post-traumatic stress disorder (PTSD) in adults. If you have PTSD and are interested in a non-traditional treatment option, this might be worth exploring.

Omaha, Nebraska

Hear when a new Post Traumatic Stress Disorder (PTSD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.